Table of Contents Table of Contents
Previous Page  148 / 398 Next Page
Information
Show Menu
Previous Page 148 / 398 Next Page
Page Background

143

histology, and immunohistochemistry using a panel of lymphoid

markers (EBV, CD79a, CD20, PAX-5, CD3, and CD30) resulted

in the diagnosis of EBV driven T-cell, B-cell, and Hodgkin-like

LPD. All three patients recovered following cessation of MTX

and surgical debridement.

Although LPD as a cause of ONJ is rare, due to the rise in

immunodeficiency disorders and immunosuppressive treatments,

the prevalence of this condition may be expected to increase. For

this reason, clinicians should be aware of the diagnosis. As this

case series has shown, biopsy and diagnostic immunohistochem-

istry will ensure the correct diagnosis. Because the diagnostic

approach used in this case series will distinguish MTX-related

LPD from the more familiar condition of Medication-related

osteonecrosis of the jaw.

http://dx.doi.org/10.1016/j.ijom.2017.02.493

Preventive effect of dental pulp-derived mesenchymal stem

cells in experimental medication-related osteonecrosis of the

jaw

Z.B. Gonen

∗

, S. Bilge, M.E. Onder, O. Etoz, D. Bahar,

A. Alkan

Erciyes University, Kayseri, Turkey

Background:

Medication-related osteonecrosis of the jaw

(MRONJ) has been a complication and the treatment still has been

main challenge of this complication.

Objectives:

The aim of this study was to investigate a prevention

strategy for MRONJ development in rat model.

Methods:

Dental pulp-derived mesenchymal stem cells (DP-

MSCs) were isolated and characterised. Green fluorescent protein

(GFP) was transfected to cells. 40 rats were divided into four

groups (Group 1: tooth extraction; Group 2: tooth extraction after

bisphosphonate therapy; Group 3: DP-MSCs application simul-

taneously with tooth extraction after bisphosphonate therapy;

Group 4: DP-MSCs application one day before of tooth extraction

after bisphosphonate therapy). The bisphosphonate therapy was

0.1 mg/kg zoledronic acid intraperitoneally once per every three

days for 9 weeks. The lower molar tooth of all animals extracted

under general anaesthesia. The animals were sacrificed after six

weeks of healing. Histologic and immunohistochemical analysis

were performed. Expression of osteocalcin, bone morphogenetic

protein 2, and Runt-related transcription factor 2 was assessed by

quantitative polymerase chain reaction analysis.

Findings:

Phenotype characterisation of the DP-MSCs demon-

strated a homogeneous population of cells negative for CD11b,

CD45 and positive for CD44, CD29, CD90, and CD105. The

alveolar sockets were complete (70%) and partial (10%) healed in

group 3 whereas the exposed necrotic bone remained in group

2. Preventive DP-MSCs treatment enhanced the expression of

osteogenic related genes. Immunohistochemical staining showed

the higher staining for those markers and GFP positivity in group

3. Histological analysis showed new bone formation and vascu-

larisation in the DP-MSCs groups.

Conclusion:

Simultaneously DP-MSCs with tooth extraction

showed preventive effects for MRONJ development.

http://dx.doi.org/10.1016/j.ijom.2017.02.494

Conservative treatment option for large odontogenic cystic

lesions/tumours — a single centre experience in Karachi,

Pakistan

S.M. Haider

∗

, F. Hameed

Abbassi Shaheed Hospital, Pakistan

Background and Objectives:

Keratocystic odontogenic tumour

(KCOT) is known for its unusual behaviour, different origin,

debatable development, controversial and disputed treatment

modalities. This study aims to present a case series of KCOT

emphasising its solvability without surgical intervention or inva-

sive procedures, and comparing its clinical, radiological and

histopathological characteristics and therapeutic alternatives to

those described in the literature.

Methods:

Our series of 7 patients with histologically proven

KCOTs were treated by marsupialisation surgery from 2003 to

2014. Radiological evaluation done in terms of reduction in lesion

size and, therefore, easy and complete removal become possible

with lower recurrence rate. Patient was followed for years with

radiology and clinical examination to detect recurrence. Good

bone integrity, less morbidity, improved quality of life and better

aesthetics were the primary.

Findings and Conclusions:

KCOT treatment is still debatable

and there is no consensus about it. In our cases bone integrity,

morbidity and functional defect related to surgical intervention

was taken into consideration so that marsupialisation was per-

formed to reduce the tumour size and followed by enucleation

gives good results. Our treatment offers long-term follow-up with

clinical examination and radiology to control the disease.

http://dx.doi.org/10.1016/j.ijom.2017.02.495

Vascular malformations of the maxillofacial skeleton — an

overview of presentation and management

A.A. Heggie

∗

, J.M. Shand, A.J. Penington

Oral and Maxillofacial Surgery Unit, Department of Plastic and

Maxillofacial Surgery, Royal Children’s Hospital of Melbourne

and Epworth Hospital, Victoria, Australia

Background:

Vascular disorders of the maxillofacial skeleton

vary from benign localised lesions to aggressive, proliferative

high-flowmalformations that present enormous challenges for the

clinician.

Objectives:

This presentation will describe the classification of

vascular malformations within the maxillofacial complex, their

characteristics and management. The distinction between arteri-

ovenous malformations (AVM) and haemangiomas will also be

highlighted to emphasise that these lesions are separate patholog-

ical entities.

Methods:

A retrospective review of patients (adults and paedi-

atric patients) with a diagnosis of a vascular lesion of the facial

skeleton was undertaken in an attempt to classify the main cate-

gories. The implications for elective and curative surgery were to

be considered and treatment protocols outlined.

Findings:

Of 13 patients with AVM’s, 6 were syndromic low-

flow arteriovenous malformations, 4 were nonsyndromic low-flow

lesions and 3 were high-flow malformations. Sturge-Weber syn-

drome is a phakomatosis due to an embryonal developmental

anomaly (mutations in the GNAQ gene) with several subtypes.